New Delhi, Oct 30 (PTI) Shares of drug firm Lupin today Also Read - Kareena Kapoor Khan is Not Sure If Taimur Ali Khan is Stretching Post Yoga Or Nap | See Photo

ended nearly 3 per cent higher even as the company posted 31.3 Also Read - Kareena Kapoor Khan Shares Strong Post on COVID-19, Says 'No Propaganda, Wear Your Mask'

per cent decline in consolidated net profit for the September Also Read - Dumbness At Its Best! Kangana Ranaut Faces Flak For Stepping Out in Mumbai Sans Mask, Suyyash Rai Trolls Her

quarter.

The stock gained 2.67 per cent to end at Rs 1,027.55 on

BSE. During the day, it rose 8.90 per cent to Rs 1,090.

The stock was the biggest gainer among the 30-share

components.

At NSE, shares of the company jumped 2.48 per cent to

close at Rs 1,025.95.

In terms of equity volume, 7.35 lakh shares of the

company were traded on BSE and over 81 lakh shares changed

hands at NSE during the day.

“The company posted lower-than-expected sales, while

EBDITA and net profit came in higher than expected,” said

Sarabjit Kour Nangra, VP Research- Pharma, Angel Broking.

Lupin today posted 31.3 per cent decline in consolidated

net profit to Rs 455 crore for the September quarter as it

continued to face pricing pressure in the US market.

The Mumbai-based company had reported a net profit of Rs

662.2 crore for the July-September period of the last fiscal.

Net sales of the company stood at Rs 3,874.2 crore for

the second quarter of 2017-18, down 8 per cent from Rs 4,211.2

crore in the year-ago period.

This is published unedited from the PTI feed.